T1	PROC 46 64	TRATAMIENTO PRECOZ
T2	DISO 71 88	NEUMONÍA COVID-19
T3	CHEM 93 109	GLUCOCORTICOIDES
#1	AnnotatorNotes T3	C0017710; Glucocorticoids; Hormone · Organic Chemical
T4	DISO 173 190	Neumonía CoVid-19
T5	DISO 199 211	inflamatoria
#2	AnnotatorNotes T5	C0021368; Inflammation; Pathologic Function
T6	PROC 278 289	Diagnóstico
#3	AnnotatorNotes T6	C0011900; Diagnosis; Diagnostic Procedure
T7	DISO 293 316	neumonía por SARS-CoV-2
T8	PROC 326 387	reacción en cadena de la polimerasa con transcriptasa inversa
#4	AnnotatorNotes T8	C0599161; Reverse Transcriptase Polymerase Chain Reaction; Molecular Biology Research Technique
T9	CHEM 366 387	transcriptasa inversa
#5	AnnotatorNotes T9	C0035379; RNA-Directed DNA Polymerase; Amino Acid, Peptide, or Protein · Enzyme
T10	ANAT 400 419	frotis nasofaríngeo
T11	ANAT 422 428	esputo
#6	AnnotatorNotes T11	C0038056; Sputum; Body Substance
T12	DISO 510 518	síntomas
#7	AnnotatorNotes T12	C1457887; Symptoms; Sign or Symptom
T13	PROC 564 583	proteína C reactiva
#8	AnnotatorNotes T13	C0201657; C-reactive protein measurement; Laboratory Procedure
T14	PROC 828 832	SpO2
#9	AnnotatorNotes T14	C0428179; Measurement of oxygen saturation at periphery; Laboratory Procedure
T15	PROC 601 616	interleuquina 6
#10	AnnotatorNotes T15	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T16	PROC 618 622	IL-6
#11	AnnotatorNotes T16	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T17	PROC 675 699	consentimiento informado
#12	AnnotatorNotes T17	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T18	DISO 730 737	Alergia
#13	AnnotatorNotes T18	C1527304; Allergic Reaction; Pathologic Function
T19	CHEM 763 786	medicamentos en estudio
#14	AnnotatorNotes T19	C0013230; Investigational New Drugs; Pharmacologic Substance
T20	DISO 800 826	insuficiencia respiratoria
#15	AnnotatorNotes T20	C0035229; Respiratory Insufficiency; Pathologic Function | C1145670; Respiratory Failure; Disease or Syndrome
T21	CHEM 929 945	glucocorticoides
#16	AnnotatorNotes T21	C0017710; Glucocorticoids; Hormone · Organic Chemical
T22	CHEM 948 964	inmunosupresores
#17	AnnotatorNotes T22	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T23	DISO 1016 1047	Diabetes mellitus descompensada
#18	AnnotatorNotes T23	C4324690; Decompensated diabetes; Disease or Syndrome
T24	DISO 1053 1074	Hipertensión arterial
#19	AnnotatorNotes T24	C0020538; Hypertensive disease; Disease or Syndrome
T25	DISO 1093 1122	Trastorno psicótico o maníaco
T26	PROC 892 901	PaO2/FiO2
#20	AnnotatorNotes T26	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T27	DISO 1127 1133	Cáncer
#21	AnnotatorNotes T27	C0006826; Malignant Neoplasms; Neoplastic Process
T28	DISO 1231 1240	infección
#22	AnnotatorNotes T28	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T29	PROC 858 862	PaO2
#23	AnnotatorNotes T29	C0428168; Measurement of partial pressure of oxygen in blood; Laboratory Procedure
T30	PROC 1328 1358	manejo conservador o paliativo
T31	PROC 1385 1399	ensayo clínico
#24	AnnotatorNotes T31	C0008976; Clinical Trials; Research Activity
T32	DISO 1414 1456	problema médico, psicológico, psiquiátrico
T33	PROC 1596 1607	seguimiento
#25	AnnotatorNotes T33	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T34	PROC 1628 1637	protocolo
#26	AnnotatorNotes T34	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T35	PROC 1640 1650	evaluación
#27	AnnotatorNotes T35	C1261322; Evaluation procedure; Health Care Activity
T36	PROC 111 149	ENSAYO CLÍNICO CONTROLADO ALEATORIZADO
#28	AnnotatorNotes T36	C0206035; Controlled Clinical Trials, Randomized; Research Activity
T37	CHEM 351 361	polimerasa
#29	AnnotatorNotes T37	C1335439; Polymerase; Amino Acid, Peptide, or Protein · Enzyme
T38	PROC 389 395	RT-PCR
#30	AnnotatorNotes T38	C0599161; Reverse Transcriptase Polymerase Chain Reaction; Molecular Biology Research Technique
T39	CHEM 564 574	proteína C
#31	AnnotatorNotes T39	C0033621; protein C; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T40	PROC 585 588	PCR
#32	AnnotatorNotes T40	C0201657; C-reactive protein measurement; Laboratory Procedure
T41	PROC 636 645	ferritina
#33	AnnotatorNotes T41	C0373607; Ferritin measurement; Laboratory Procedure
T42	ANAT 1066 1074	arterial
#34	AnnotatorNotes T42	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T43	PROC 1201 1215	procalcitonina
#35	AnnotatorNotes T43	C1535922; Procalcitonin measurement; Laboratory Procedure
T44	Date 13 17	2020
T45	Age 266 274	≥18 años
T46	LIVB 306 316	SARS-CoV-2
#36	AnnotatorNotes T46	C5203676; SARS-CoV-2; Virus
T47	Duration 519 527	≥ 7 días
T52	PHYS 1145 1153	Embarazo
#37	AnnotatorNotes T52	C0032961; Pregnancy; Organism Function
T53	PHYS 1156 1165	lactancia
#38	AnnotatorNotes T53	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T54	Spec_cue 1170 1178	Sospecha
T55	LIVB 1260 1270	SARS-CoV-2
#39	AnnotatorNotes T55	C5203676; SARS-CoV-2; Virus
T56	LIVB 1275 1283	Paciente
#40	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1316 1324	Paciente
#41	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1544 1552	paciente
#42	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T61	ANAT 814 826	respiratoria
#43	AnnotatorNotes T61	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
T48	Neg_cue 1248 1259	diferente a
T49	PROC 1287 1311	manejo extrahospitalario
#44	AnnotatorNotes T49	C0086751; Health Services, Outpatient; Health Care Activity
T50	Neg_cue 1572 1574	no
A1	Assertion T28 Speculated
A2	Assertion T55 Negated
A3	Assertion T33 Negated
A4	Assertion T19 Contraindicated
A5	Status T18 History_of
#45	AnnotatorNotes T2	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#46	AnnotatorNotes T4	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#47	AnnotatorNotes T7	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#48	AnnotatorNotes T10	C0444192; Nasopharyngeal swab (specimen); Body Substance 
T51	Neg_cue 1075 1077	no
T58	Quantifier_or_Qualifier 1078 1088	controlada
A6	Assertion T58 Negated
T60	Quantifier_or_Qualifier 1494 1504	controlado
A7	Assertion T60 Negated
T62	Neg_cue 1491 1493	no
T63	Observation 1526 1552	participación del paciente
A8	Assertion T63 Contraindicated
#49	AnnotatorNotes T63	C1278516; Patient participation status; Finding
T64	Observation 1610 1650	adherencia con el protocolo y evaluación
A9	Assertion T64 Negated
R1	Negation Arg1:T62 Arg2:T60	
R2	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T60	
R3	Negation Arg1:T50 Arg2:T33	
R4	Negation Arg1:T50 Arg2:T64	
R7	Experiences Arg1:T59 Arg2:T32	
R9	Before Arg1:T32 Arg2:T63	
R10	Before Arg1:T32 Arg2:T33	
R11	Before Arg1:T32 Arg2:T35	
R5	Used_for Arg1:T3 Arg2:T1	
T65	Quantifier_or_Qualifier 212 218	precoz
#50	AnnotatorNotes T65	C1279930; Precocious; Temporal Concept
T66	Quantifier_or_Qualifier 220 230	estadío II
R12	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T66	
R13	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T65	
R14	Overlap Arg1:T4 Arg2:T5	
R15	Causes Arg1:T46 Arg2:T7	
R18	Location_of Arg1:T10 Arg2:T38	
R19	Location_of Arg1:T11 Arg2:T38	
R20	Location_of Arg1:T11 Arg2:T8	
R21	Location_of Arg1:T10 Arg2:T8	
R22	Before Arg1:T8 Arg2:T6	
R23	Before Arg1:T38 Arg2:T6	
R24	Has_Duration_or_Interval Arg1:T12 Arg2:T47	
T67	Result_or_Value 590 598	>60 mg/L
R25	Has_Result_or_Value Arg1:T13 Arg2:T67	
R26	Has_Result_or_Value Arg1:T40 Arg2:T67	
T68	Result_or_Value 624 633	>40 pg/mL
R27	Has_Result_or_Value Arg1:T16 Arg2:T68	
R28	Has_Result_or_Value Arg1:T15 Arg2:T68	
T69	Result_or_Value 646 656	>1000 µg/L
R29	Has_Result_or_Value Arg1:T41 Arg2:T69	
R30	Causes Arg1:T19 Arg2:T18	
R31	Location_of Arg1:T61 Arg2:T20	
T70	Result_or_Value 833 837	<90%
R32	Has_Result_or_Value Arg1:T14 Arg2:T70	
T71	Quantifier_or_Qualifier 839 854	a aire ambiente
R33	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T71	
T72	Result_or_Value 863 871	<60 mmHg
R34	Has_Result_or_Value Arg1:T29 Arg2:T72	
T73	Quantifier_or_Qualifier 873 888	a aire ambiente
R35	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T73	
T74	Result_or_Value 902 910	<300 mmH
R36	Has_Result_or_Value Arg1:T26 Arg2:T74	
T75	Quantifier_or_Qualifier 980 990	biológicos
#51	AnnotatorNotes T75	C0205460; biological; Qualitative Concept 
R40	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T75	
R41	Location_of Arg1:T42 Arg2:T24	
R42	Negation Arg1:T51 Arg2:T58	
R43	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T58	
T76	Quantifier_or_Qualifier 1134 1140	activo
#52	AnnotatorNotes T76	C0679217; Active State; Idea or Concept
R44	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T76	
#53	AnnotatorNotes T25	C0024713; Manic Disorder; Mental or Behavioral Dysfunction | C0033975; Psychotic Disorders; Mental or Behavioral Dysfunction
R45	Speculation Arg1:T54 Arg2:T28	
R46	Negation Arg1:T48 Arg2:T55	
T77	Result_or_Value 1216 1226	>0,5 ng/mL
R47	Has_Result_or_Value Arg1:T43 Arg2:T77	
T78	Quantifier_or_Qualifier 1241 1247	activa
#54	AnnotatorNotes T78	C0679217; Active State; Idea or Concept
R48	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T78	
R50	Experiences Arg1:T56 Arg2:T49	
R51	Experiences Arg1:T57 Arg2:T30	
T79	Observation 1363 1399	Participación en otro ensayo clínico
T80	Observation 1414 1422;1458 1477	problema geográfico o social
R52	Has_Quantifier_or_Qualifier Arg1:T80 Arg2:T60	
T81	Quantifier_or_Qualifier 1478 1488	importante
#55	AnnotatorNotes T81	C3898777; Important; Qualitative Concept
R53	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T81	
R54	Has_Quantifier_or_Qualifier Arg1:T80 Arg2:T81	
R55	Before Arg1:T80 Arg2:T63	
R56	Before Arg1:T80 Arg2:T33	
R57	Before Arg1:T80 Arg2:T64	
#56	AnnotatorNotes T1	C1964029; early/brief intervention/therapy (treatment); Therapeutic or Preventive Procedure (?) 
#57	AnnotatorNotes T30	C0459914; Conservative Treatment; Therapeutic or Preventive Procedure | C0030231; Palliative Care; Therapeutic or Preventive Procedure
#58	AnnotatorNotes T32	C5441915; Medical problem; Finding | C0849888; psychological disturbance; Mental or Behavioral Dysfunction | C1306597; Psychiatric problem; Mental or Behavioral Dysfunction 
A10	Experiencer T56 Patient
A11	Experiencer T57 Patient
A12	Experiencer T59 Patient
